Latest News

Holding(s) in Company

Notification of major interests in shares

Cardiotox Platform Launch

Miscellaneous medium priority announcements

Holding(s) in Company

Notification of major interests in shares

Physiomics wins new deal with global pharma

Oxford-based biology company Physiomics has signed a new contract with a global pharmaceutical company. The project...

All News

13-10-14Holding(s) in CompanyRNS
07-10-14Cardiotox Platform LaunchRNS
29-08-14Holding(s) in CompanyRNS
14-08-14Physiomics wins new deal with global pharmaStockMarketWire
14-08-14New deal with global pharmaRNS
24-07-14Physiomics raises up to £562,500StockMarketWire
24-07-14Issue of EquityRNS
26-06-14Holding(s) in CompanyRNS
12-06-14Physiomics in anticipated new collaboration with DiatechStockMarketWire
12-06-14Anticipated new collaboration with DiatechRNS
20-05-14Holding(s) in CompanyRNS
10-04-14Second validation of Virtual Tumour ClinicalRNS
03-04-14Virtual Tumour Clinical ValidationRNS
14-02-14Physiomics narrows H1 pretax loss to £0.21mStockMarketWire
14-02-14Half Yearly ReportRNS
30-01-14Issue of Equity - ReplacementRNS
30-01-14Physiomics issues shares under SEDAStockMarketWire
30-01-14Issue of EquityRNS
16-01-14Physiomics to work with Dundee UniversityStockMarketWire
16-01-14Dundee University CollaborationRNS
17-12-13Physiomics resolutions passed at AGMStockMarketWire
17-12-13Result of AGMRNS
04-12-13Physiomics wins pharmaceutical contractStockMarketWire
04-12-13Virtual Tumour ProposalRNS
28-11-13Physiomics launches DrugCARD databaseStockMarketWire
28-11-13DrugCARD launchRNS
15-11-13Physiomics narrows FY pretax loss to £0.54mStockMarketWire
15-11-13Final ResultsRNS
11-11-13Physiomics in virtual tumour research collaborationStockMarketWire
11-11-13University of Oxford CollaborationRNS
04-11-13Update on the Virtual Tumour Clinical platformRNS
10-10-13Trends and Targets for 11/10/2013Trends and Targets
10-10-13Upcoming info.Trends and Targets
10-10-13Physiomics draws down £240,000StockMarketWire
10-10-13Drawdown pursuant to SEDA Arrngmnt/Issue of EquityRNS
07-10-13Physiomics gains new speciality pharma customerRNS
01-10-13Physiomics sign up large new customerStockMarketWire
01-10-13Physiomics gains first large pharma customerRNS
16-09-13Physiomics to present cardiac toxicity platformRNS
26-07-13Physiomics in equity issueStockMarketWire

RSS feeds

  • Editorial news feed for LSE:PYC Editorial
  • Regulatory news feed for LSE:PYC Regulatory